WebFeb 24, 2024 · Cytokinetics press release (NASDAQ: CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51. Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M. Cash, cash equivalents and investments totaled $623.7 million... WebFeb 22, 2024 · This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues are expected to be $7.46...
Did you know?
WebFeb 28, 2024 · February 28, 2024 — 08:40 am EST. Written by Zacks Equity Research for Zacks ->. Investors are always looking for stocks that are poised to beat at earnings season and Cytokinetics, Incorporated ... WebApr 9, 2024 · As a group, equities analysts anticipate that Cytokinetics, Incorporated will post -4.4 EPS for the current fiscal year. Cytokinetics Company Profile . Cytokinetics, Inc is a biopharmaceutical ...
WebFeb 25, 2024 · Cytokinetics (NASDAQ:CYTK): Q4 GAAP EPS of -$0.62 misses by $0.13.Revenue of $6.72M (+29.0% Y/Y) misses by $13.17M.Press Release … WebApr 12, 2024 · Cytokinetics, Incorporated has a 1 year low of $32.96 and a 1 year high of $55.80. Cytokinetics ( NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The...
WebFind the latest Revenue & EPS data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) Revenue EPS Nasdaq Skip to main content WebA company's earnings per share, or EPS, is a key financial metric on its income statement that investors and analysts use to assess its performance and stock price. EPS is the net …
WebApr 13, 2024 · During the same quarter in the previous year, the firm posted ($0.36) EPS. Research analysts predict that Cytokinetics, Incorporated will post -4.4 earnings per share for the current fiscal year. Insiders Place Their Bets. In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday ...
WebCytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes and mast cells, as well as endothelial cells, fibroblasts, … ps5 best headsetWebFlu-like symptoms (chills, fever, headache, fatigue, loss of appetite, nausea, vomiting) Low white blood cell counts (which increase the risk of infection) Skin rashes. … ps5 black backgroundWebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement to their … retreat getaways knoxville tnWebApr 5, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … ps5 biographieWebApr 10, 2024 · The company is expected to report EPS of $2.50, down 6.37% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $23.56 billion, up 0.59% from ... retreat germantown tnWebCytokinetics is headquartered in South San Francisco, California, the US. Headquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD) retreat glasgowWebFeb 20, 2015 · VA DIRECTIVE 6518 3 ENTERPRISE INFORMATION MANAGEMENT (EIM) 1. PURPOSE. To establish the importance of VA’s information resources as … retreat glasshouse candles